What precautions should be taken with vaccines during cosentyx use?

Live Vaccines and Cosentyx

Cosentyx (secukinumab), an IL-17A inhibitor for psoriasis, psoriatic arthritis, and ankylosing spondylitis, suppresses immune responses. Avoid live vaccines during treatment and for at least 4-6 weeks after the last dose, as they can cause infection in immunocompromised patients.[1][2] Examples include MMR, varicella, oral polio, and yellow fever vaccines.

Non-Live Vaccines

Inactivated or recombinant vaccines (e.g., flu shot, Tdap, HPV, pneumococcal) are generally safe and recommended. However, antibody responses may be reduced, so vaccinate before starting Cosentyx if possible.[1][3] Check titers post-vaccination for high-risk patients.

Timing Recommendations

• Complete all vaccinations per CDC schedule before initiating Cosentyx.
  
• If urgent, administer non-live vaccines during treatment but monitor efficacy.
  
• Wait 4 weeks after stopping Cosentyx before live vaccines; consult prescriber for individualized timing.[2][4]
  
  

Special Cases

• Pregnancy/breastfeeding: Limited data; avoid live vaccines and discuss with doctor.
  
• Recent infection: Delay vaccination until resolved.
  
• Travel: Prioritize non-live options; avoid live vaccines for endemic areas.[3][5]
  
  Patients on Cosentyx should inform vaccinators of their treatment to avoid live vaccines. Report any post-vaccination infections immediately.
  
  Sources
  [1]: Cosentyx Prescribing Information (Novartis)
  [2]: FDA Label for Secukinumab
  [3]: CDC Vaccine Guidelines for Immunocompromised Adults
  [4]: American College of Rheumatology Guidelines
  [5]: IDSA Vaccination in Immunosuppressed Patients